Dynavax Technologies Corp (NAS:DVAX)
$ 11.44 0.18 (1.6%) Market Cap: 1.50 Bil Enterprise Value: 1.03 Bil PE Ratio: 190.67 PB Ratio: 2.42 GF Score: 74/100

Q4 2023 Dynavax Technologies Corp Earnings Call Transcript

Feb 22, 2024 / 09:30PM GMT
Release Date Price: $12.44 (-0.16%)
Operator

Good day, ladies and gentlemen, and welcome to the Dynavax Technologies Fourth Quarter and Full Year 2023 financial results conference call. As a reminder, this call is being recorded at the end of the Company's prepared remarks will open the call for questions and for five Pacific instructions at that time. I would now like to turn the call over to Paul Cox, Vice President, Investor Relations and Corporate Communications. You may begin.

Paul Cox
Dynavax Technologies Corp - VP, IR & Corporate Communications

Thank you for participating in today's call. Joining me from Dynavax are Ryan Spencer, Chief Executive Officer, Dan Caruso, Chief Commercial Officer, Rob Janssen, Chief Medical Officer, and Kelly MacDonald, Chief Financial Officer.

Earlier today, Dynavax released financial results for the fourth quarter and full year ended December 31st, 2023 copies of the press release and a supplementary slide presentation are available on Dynavax's website.

Before we begin, I advise you that we will be making forward-looking statements today based

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot